Probable risk of tumour induction after retro-orbital irradiation for Graves' ophthalmopathy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8850428.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Retrobulbar irradiation for Graves' ophthalmopathy is considered as a safe treatment and has recently been recommended as the initial treatment for patients with moderately severe eye problems. However, calculations using risk factors presently known reveal a theoretical risk of radiation-induced cancer of 1.2%. Therefore, the authors suggest that this treatment should be reserved for the elderly patient, for example above the age of 40-50 years.
Medical subject headings
- Eye Diseases
- Graves Disease
- Neoplasms, Radiation-Induced